208 related articles for article (PubMed ID: 9243149)
1. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
[TBL] [Abstract][Full Text] [Related]
2. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
Lu HR; Lijnen HR; Stassen JM; Collen D
Blood; 1991 Jul; 78(1):125-31. PubMed ID: 1906351
[TBL] [Abstract][Full Text] [Related]
3. Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group.
Lancet; 1989 Apr; 1(8643):863-8. PubMed ID: 2564949
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic treatment of acute pulmonary embolism.
Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis.
Martin U; Sponer G; Strein K
J Am Coll Cardiol; 1992 Feb; 19(2):433-40. PubMed ID: 1732372
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and management of acute pulmonary embolism.
D'Orio V; Mendes P; Saad G; Marcelle R
Acta Clin Belg; 1989; 44(6):396-408. PubMed ID: 2516949
[TBL] [Abstract][Full Text] [Related]
7. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
8. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.
Dalla-Volta S; Palla A; Santolicandro A; Giuntini C; Pengo V; Visioli O; Zonzin P; Zanuttini D; Barbaresi F; Agnelli G
J Am Coll Cardiol; 1992 Sep; 20(3):520-6. PubMed ID: 1512328
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic treatment in acute myocardial infarction.
Verstraete M
Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism.
Meyer G; Sors H; Charbonnier B; Kasper W; Bassand JP; Kerr IH; Lesaffre E; Vanhove P; Verstraete M
J Am Coll Cardiol; 1992 Feb; 19(2):239-45. PubMed ID: 1732347
[TBL] [Abstract][Full Text] [Related]
11. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
12. [The value of thrombolysis for the treatment of acute pulmonary embolism].
Marbet GA
Schweiz Med Wochenschr; 1989 Oct; 119(43):1498-505. PubMed ID: 2514456
[TBL] [Abstract][Full Text] [Related]
13. Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.
Levine MN
Chest; 1991 Apr; 99(4 Suppl):128S-134S. PubMed ID: 2009809
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism.
Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H
Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic treatment of pulmonary embolism.
Palevsky HI; Raffin TA
West J Med; 1992 Aug; 157(2):171. PubMed ID: 1441471
[No Abstract] [Full Text] [Related]
17. Thrombolytic therapy for venous thromboembolism.
Goldhaber SZ
Baillieres Clin Haematol; 1990 Jul; 3(3):693-704. PubMed ID: 2271787
[No Abstract] [Full Text] [Related]
18. Reperfusion pulmonary edema after thrombolytic therapy of massive pulmonary embolism.
Ward BJ; Pearse DB
Am Rev Respir Dis; 1988 Nov; 138(5):1308-11. PubMed ID: 3202486
[TBL] [Abstract][Full Text] [Related]
19. Coronary thrombolysis for evolving myocardial infarction.
Spann JF; Sherry S
Drugs; 1984 Nov; 28(5):465-83. PubMed ID: 6391890
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
